.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Chinese Patent Office
Novartis
McKinsey
Moodys
Citi
Teva
Fish and Richardson
Boehringer Ingelheim
Harvard Business School

Generated: June 28, 2017

DrugPatentWatch Database Preview

BECONASE AQ Drug Profile

« Back to Dashboard

What is the patent landscape for Beconase Aq, and when can generic versions of Beconase Aq launch?

Beconase Aq is a drug marketed by Glaxosmithkline and is included in one NDA.

The generic ingredient in BECONASE AQ is beclomethasone dipropionate monohydrate. There are twenty drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the beclomethasone dipropionate monohydrate profile page.

Summary for Tradename: BECONASE AQ

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list32
Clinical Trials: see list2
Patent Applications: see list251
Drug Prices:see details
DailyMed Link:BECONASE AQ at DailyMed

Pharmacology for Tradename: BECONASE AQ

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline
BECONASE AQ
beclomethasone dipropionate monohydrate
SPRAY, METERED;NASAL019389-001Jul 27, 1987RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
US Army
Queensland Health
Express Scripts
Novartis
McKesson
Boehringer Ingelheim
Farmers Insurance
Argus Health
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot